#evaluate(de(' #AdditionalMetaTags# '))#
Positrigo's vision is to image everyone. Offering innovative solutions for providing functional brain positron emission tomography scans to the masses, our first focus is the early detection of Alzheimer's Disease. With the advent of treatments like Leqembi and Kisunla, an early and reliable diagnostic technique is of utmost importance. This is where Positrigo will provide a solution with which healthcare providers, such as imaging centers and neurologists, can make more functional brain scans on the same space for lower cost than today.
Positrigo raises CHF 7 million to commercialise its brain imaging device (startupticker.ch)
Positrigo raises CHF 7M to accelerate nuclear brain imaging device production (venturelab.swiss)
Four startups tap into new markets through strategic partnerships (startupticker.ch)
A good start in the US for four startups (startupticker.ch)
Regulatory approval for MachineMD and Positrigo’s devices (startupticker.ch)
Positrigo receives FDA approval for NeuroLF (startupticker.ch)
TechTour Growth: A showcase for Switzerland’s Deeptech prowess (startupticker.ch)
Sparks IPO Academy prepares new cohort for next move (startupticker.ch)
Positrigo prepares for market entry (startupticker.ch)
Innosuisse Scale-up Coaching programme to boost 17 start-ups (startupticker.ch)
Swiss Accelerator: Innosuisse supports 53 companies with CHF112 million (startupticker.ch)
Swiss startups accelerate precision medicine and value-based healthcare (startupticker.ch)
The 16 most promising medtech startups in 2022, according to investors (TOP 100)
Positrigo raises CHF 5.5 million to proceed with commercialization (venturelab.swiss)
Positrigo ready for the commercialisation phase after raising CHF 5.5 million (startupticker.ch)
Strong Swiss delegation at Medica (startupticker.ch)
Update TOP 100 Public Voting 2022: Bearmind, Positrigo, and Spirecut lead the medtech field (TOP 100)
IMD 37 Startup Competition 2022 Winners announced (startupticker.ch)
10 Venture Leaders pitch to Chinese investors and enterprises in fourth Swiss-Sino Pitchinar (venturelab.swiss)
The Venture Leaders Deeptech leave their marks with investors in Munich and London (venturelab.swiss)
All IEC60601 tests successfully passed in accredited test lab
First Prototype ready
Horizon 2020 SME Phase 1
NeuroLF Product Presentation
Pitch Venture Leaders Kufe Science 2019
SCSN 2019